Cardiac Pathways Corp

About:

Cardiac Pathways manufactures minimally-invasive systems for electrophysiologists to diagnose and treat cardiac tachyarrhythmia.

Top Investors: Scale Venture Partners, Morgan Stanley Expansion Capital, State of Wisconsin Investment Board, Van Wagoner Ventures, LLC

Description:

Cardiac Pathways Corp manufactures minimally-invasive systems used by electrophysiologists to diagnose and treat cardiac tachyarrhythmia (abnormally rapid heart rhythms), which if untreated can cause palpitations, fainting, and sudden cardiac arrest. Cardiac Pathways' products consist principally of systems for performing ablation treatment (a nonsurgical, minimally-invasive technique for neutralizing heart tissue responsible for starting or maintaining a tachyarrhythmia) and for diagnostic mapping (locating the source of the tachyarrhythmia within the heart). Cardiac Pathways was issued a U.S. patent related to its Real-time Position Management Tracking System. Founded in 1991, Cardiac Pathways is based in Sunnyvale, California. As of August 6, 2001, it was acquired by Boston Scientific Corporation.